Baldwin spearheading bill requiring drug companies to justify price hikes

epipen

A new bill proposed in Congress would require more transparency from drug companies if they want to raise the price of their products. The Fair Accountability and Innovative Research (FAIR) Drug Pricing Act is a bipartisan effort being spearheaded by Sen. Tammy Baldwin, Sen. John McCain (R-AZ) and Rep. Jan Schakowsky (D-IL). > Wisconsin Public Radio

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s